|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| C07K 16/18 | |||
| A61K 31/122 | |||
| A61K 31/352 | |||
| A61K 31/565 | |||
| A61K 31/593 | |||
| A61K 31/663 | |||
| A61K 38/23 | |||
| A61K 45/00 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| C12N 5/10 | |||
| C12P 21/08 |
| (11) | Number of the document | 2907826 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15161779.2 |
| Date of filing the European patent application | 2008-10-08 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2007265420 | 2007-10-11 | JP |
| (72) |
Hiruma, Yoshiharu, JP
Tsuda, Eisuke, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426,
JP
|
| (54) | ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15 |
| ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15 |